Firestormm
Senior Member
- Messages
- 5,055
- Location
- Cornwall England
'The response from Broderick clarifies that the original publication, in its current format, is intended only for application in clinical settings and that its use in research settings should await the publication of a related International Symptom Scale, currently being developed. Neither letter addresses the consequences of the new criteria for medical-legal issues such as reimbursement or disability assessment, particularly for those who might meet the 1994 Fukuda criteria for CFS but do not fully meet the new criteria for M.E. The response from Broderick on behalf of the author panel also does not address the uneven access to testing that is proposed to confirm the presence of subjective symptoms, especially if intended to be employed in the clinical setting to make a diagnosis. These issues are top-of-mind for the autism and Alzheimers communities, as the definitions for those conditions are being narrowed (autism, see New York Times, Jan. 19, 2012 and Medical News Today, Jan. 24, 2012) and expanded (Alzheimers, see Los Angeles Times, April 25, 2011). [http://forums.phoenixrising.me/show...efinition-for-autism-implications-for-CFS-ME]
The discussion of these criteria will certainly continue, especially when the related scale and physician guidelines are published.'
CFIDS 24 January 2012: http://www.research1st.com/2012/01/...&utm_campaign=Feed:+Research1st+(Research1st)
The discussion of these criteria will certainly continue, especially when the related scale and physician guidelines are published.'
CFIDS 24 January 2012: http://www.research1st.com/2012/01/...&utm_campaign=Feed:+Research1st+(Research1st)